You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (1) |
Back to Search
EARLIER ACCESS TO INNOVATION: ADAPTIVE LICENSING COMBINED WITH RISK SHARING - INTERIM RESULTS
- In: What’s new in industry and science? Part 2 on Thursday, 26 September 2019, 11:00-11:10
- At: AbuDhabi (United Arab Emirates) (2019)
- Type: Presentation
- By: HOLBEIN, Baerbel (University of Bremen, Duale Hochschule Baden-Württemberg, Germany)
- Co-author(s): Baerbel Holbein: University of Bremen, Duale Hochschule Baden-Württemberg, Bremen, Bad Mergentheim, Germany
- Abstract:
Background
Risk sharing agreements (RSA) between pharmaceutical companies, health insurers and payers already exist. One crucial question is what a risk sharing model could look like if applied for the clinical trial program with adaptive licensing pathways.
Methods
Drugs recently approved by both FDA and EMA, particularly the new CAR T
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026